Hermetica Superfood Encyclopedia
The Short Answer
Dieckol is a dimeric phlorotannin extracted from the brown alga Ecklonia cava that exerts anti-inflammatory effects primarily by inhibiting STAT1 phosphorylation at Ser727 and blocking nuclear translocation, thereby suppressing inflammatory cytokine production. In HaCaT keratinocyte models, dieckol at 12.5 μM reduced IFN-γ-induced MDC/CCL22 production to 135 ± 12.7 pg/mL, outperforming the reference antioxidant EGCG at 10 μM in direct comparison.
CategoryExtract
GroupMarine-Derived
Evidence LevelPreliminary
Primary Keyworddieckol benefits
Dieckol — botanical close-up
Health Benefits
**Anti-inflammatory Activity**
Dieckol suppresses IFN-γ-induced production of the chemokine MDC/CCL22 in human keratinocytes by inhibiting STAT1 phosphorylation at Ser727 and blocking its nuclear translocation, demonstrating potency superior to EGCG at comparable concentrations.
**Antioxidant Protection**
Dieckol attenuates particulate matter (PM10)-induced lipid peroxidation in keratinocytes more effectively than the related phlorotannin eckol, reducing oxidative stress markers and inflammatory cytokines including TNF-α, IL-1β, and IL-6.
**Anticancer Potential**
Dieckol induces apoptosis in ovarian cancer cell lines A2780 and SKOV3 with IC50 values of 77.31 ± 0.017 μM and 92.7 ± 0.013 μM respectively, and suppressed tumor growth in a SKOV3 xenograft mouse model without notable adverse effects.
**Pro-apoptotic Signaling**
Dieckol activates both the extrinsic (caspase-8) and intrinsic (caspase-9) apoptotic pathways, converging on caspase-3 effector activation; selective caspase inhibitors block this cascade, confirming mechanistic specificity.
**Anti-diabetic Effects**
Preclinical investigations indicate dieckol modulates glycemic pathways, contributing to reported anti-diabetic properties of Ecklonia cava phlorotannin fractions, though specific molecular targets in glucose metabolism require further elucidation.
**Skin and Dermatological Protection**
By attenuating PM10-induced cytokine release and STAT1-mediated chemokine production, dieckol shows promise for managing inflammatory skin conditions such as atopic dermatitis, supported by multiple in vitro keratinocyte studies.
**Radioprotective and Anti-aging Properties**
Broader preclinical data attribute radioprotective, anti-hyperlipidemic, anti-platelet, and anti-aging activities to dieckol, reflecting its diverse polyphenolic reactivity with free radicals and inflammatory mediators.
Origin & History
Natural habitat
Dieckol is a phlorotannin polyphenol isolated from Ecklonia cava, a brown macroalga native to the intertidal and subtidal zones of East Asian coastal waters, particularly along the coasts of Korea, Japan, and China. Ecklonia cava thrives in cold, nutrient-rich marine environments and is harvested both from wild populations and through aquaculture operations. The alga has long been consumed as a food source in East Asian cultures, and modern extraction processes concentrate its bioactive phlorotannin fraction, of which dieckol is the most pharmacologically studied constituent.
“Ecklonia cava, the source organism for dieckol, has been harvested and consumed as an edible seaweed in Korea, Japan, and coastal China for centuries, integrated into traditional diets and folk medicine systems as a general health tonic attributed with vitality-enhancing and wound-healing properties. In Korean traditional medicine, brown seaweeds including Ecklonia species were used in preparations intended to support digestive health and reduce inflammation, though dieckol as a discrete chemical entity was not historically identified or isolated. The systematic isolation and characterization of phlorotannins, including dieckol, began with the advent of modern chromatographic techniques in the late 20th century, transitioning the ingredient from a cultural food component to a subject of pharmacological investigation. Contemporary research interest in dieckol has been driven primarily by South Korean and Japanese academic institutions, reflecting the deep cultural and economic significance of Ecklonia cava mariculture in those regions.”Traditional Medicine
Scientific Research
The current evidence base for dieckol is composed entirely of in vitro cell culture studies and limited animal experiments, with no published human clinical trials identified in the available literature as of 2024. Key in vitro work includes cytotoxicity assays in ovarian cancer lines (A2780, SKOV3), mechanistic studies in HaCaT keratinocytes elucidating STAT1 signaling, and PM10-induced oxidative stress models, all providing quantified IC50 and concentration-response data. One in vivo study employed a SKOV3 xenograft mouse model demonstrating tumor growth suppression by dieckol without significant adverse effects, though sample sizes and precise effect magnitudes were not fully reported in available summaries. Rat pharmacokinetic data characterize IV-administered Ecklonia cava phlorotannin extract behavior (clearance 193 mL/h/kg, volume of distribution 3350 mL/kg, plasma detection up to 36 hours), but oral bioavailability in humans remains unquantified, substantially limiting translation of preclinical findings.
Preparation & Dosage
Traditional preparation
**Ethanol Extract (Standardized Phlorotannin Fraction)**
9 mg dieckol per gram of Ecklonia cava biomass using ethanol solvent; used in preclinical research as the primary preparation method
No established human dose; extraction yields up to 2..
**Ethyl Acetate Fraction**
Enriches dieckol and co-occurring phlorotannins (eckol, bieckols) with total phenolic content reaching up to 89 μg GAE/mg extract; used in anti-inflammatory in vitro studies.
**GRAS Solvent Bioprocess Extracts**
High-yield recovery methods employing food-safe solvents are described in the literature for potential nutraceutical formulation, though no commercial standardized supplement has an established clinical dose.
**In Vitro Active Concentrations**
Anti-inflammatory effects observed at 12.5 μM in keratinocyte models; cytotoxic IC50 values range from 77–93 μM in ovarian cancer lines; these concentrations are not directly translatable to human supplemental doses.
**Timing and Form Notes**
Oral bioavailability is expected to be limited based on rapid IV clearance kinetics in rats; enteric protection or nanoencapsulation strategies are under exploratory investigation but not yet clinically validated.
Nutritional Profile
Dieckol is a pure phlorotannin polyphenol (molecular formula C36H22O18, molecular weight approximately 742 g/mol) and does not contribute macronutrients, vitamins, or minerals in its isolated form. Within whole Ecklonia cava biomass, the alga provides dietary fiber, iodine, magnesium, calcium, and omega-3 fatty acids alongside a complex polyphenol matrix including eckol, 6,6'-bieckol, 8,8'-bieckol, 7-phloroeckol, and phlorofucofuroeckol A (PFF-A), all of which may contribute synergistic bioactivity. Total phenolic content of ethyl acetate-enriched extracts reaches up to 89 μg gallic acid equivalents per milligram of extract, with dieckol quantifiable by HPLC-MS at concentrations up to 2.9 mg per gram of dry biomass. Bioavailability of dieckol is presumed low via oral routes based on rat pharmacokinetic data showing rapid systemic clearance (193 mL/h/kg IV), and aqueous solubility limitations may further restrict gastrointestinal absorption without formulation enhancement.
How It Works
Mechanism of Action
Dieckol's anti-inflammatory mechanism centers on inhibition of the JAK-STAT signaling axis: it suppresses IFN-γ-driven phosphorylation of STAT1 at Serine 727, preventing nuclear translocation and downstream transcription of inflammatory chemokines such as MDC/CCL22 in keratinocytes. Its pro-apoptotic activity in cancer cells involves concurrent activation of caspase-8 (extrinsic death receptor pathway) and caspase-9 (intrinsic mitochondrial pathway), both converging on executioner caspase-3 cleavage, as confirmed by pathway-specific inhibitor blockade experiments. Dieckol also scavenges reactive oxygen species and attenuates lipid peroxidation induced by environmental particulate matter, likely through direct radical quenching by its polyphenolic hydroxyl groups and modulation of redox-sensitive NF-κB signaling controlling TNF-α, IL-1β, and IL-6 expression. Additional molecular interactions implicated in its broader bioactivities include inhibition of platelet aggregation pathways, modulation of lipid metabolism enzymes, and interaction with fungal membrane targets, collectively reflecting its multitarget phlorotannin pharmacology.
Clinical Evidence
No human clinical trials investigating dieckol as an isolated compound or as a standardized Ecklonia cava fraction have been reported in the available scientific literature. The sole in vivo efficacy data derive from a SKOV3 ovarian cancer xenograft mouse model, which demonstrated tumor suppression without significant toxicity signals, but lacked detailed reporting of sample sizes, statistical power, or precise effect sizes. Pharmacokinetic characterization in rats provides mechanistic insight into distribution and elimination but cannot substitute for human bioavailability and dose-finding studies. Confidence in translating preclinical findings to human therapeutic outcomes remains very low, and dieckol should currently be regarded as a research-stage compound requiring rigorous clinical investigation before efficacy or safety claims can be established in humans.
Safety & Interactions
Dieckol demonstrated no significant adverse effects in a SKOV3 xenograft mouse model, and Ecklonia cava-derived extracts have a favorable preclinical toxicity profile consistent with their long history of dietary consumption in East Asia; however, the absence of controlled human safety studies means that a formal human maximum tolerated dose, no-observed-adverse-effect level, or adverse event profile cannot be defined. No documented drug interactions exist for isolated dieckol in the human clinical literature; theoretically, its anti-platelet and potential hypoglycemic activities in preclinical models raise concern for additive effects with anticoagulant medications (e.g., warfarin, clopidogrel) and antidiabetic agents, warranting caution until interaction studies are conducted. Contraindications, pregnancy safety, and lactation guidance cannot be established given the complete absence of clinical trial data, and use during pregnancy or lactation should be avoided on the precautionary principle. Individuals with iodine sensitivity or thyroid disorders should exercise additional caution when consuming whole Ecklonia cava preparations, as the intact alga contains iodine, though this concern is less relevant for purified dieckol isolates.
Synergy Stack
Hermetica Formulation Heuristic
Also Known As
brown algae polyphenoldieckol phlorotanninEC phlorotannin fractionDieckol (Ecklonia cava phlorotannin)Ecklonia cava phlorotanninC36H22O18
Frequently Asked Questions
What is dieckol and where does it come from?
Dieckol is a dimeric phlorotannin polyphenol isolated from Ecklonia cava, a brown macroalga native to the coastal waters of Korea, Japan, and China. It belongs to a class of marine-specific phenolic compounds called phlorotannins, which are unique to brown seaweeds and structurally distinct from terrestrial plant tannins. Dieckol is one of the most abundant and pharmacologically active phlorotannins in Ecklonia cava, typically extracted using ethanol or ethyl acetate fractionation methods.
What are the proven benefits of dieckol?
All currently demonstrated benefits of dieckol are based on preclinical in vitro and animal studies, with no human clinical trials published to date. In cell culture models, dieckol suppresses inflammatory chemokine MDC/CCL22 production at 12.5 μM by blocking STAT1 phosphorylation, induces apoptosis in ovarian cancer lines with IC50 values of approximately 77–93 μM via caspase-3/8/9 activation, and reduces PM10-induced oxidative stress and cytokine release in skin cells. Translation of these findings to human health benefits has not been clinically validated.
What is the recommended dosage of dieckol for humans?
No standardized human dosage for dieckol has been established, as no clinical trials have been conducted in human subjects. Active concentrations in cell-based studies range from 12.5 to 93 μM depending on the biological effect studied, but these laboratory concentrations cannot be directly converted to safe or effective human supplemental doses without pharmacokinetic and dose-escalation data. Rat intravenous pharmacokinetic studies show rapid systemic clearance of Ecklonia cava phlorotannin extract, suggesting oral bioavailability may be limited, further complicating dose estimation.
Is dieckol safe to take as a supplement?
Dieckol showed no significant adverse effects in a mouse xenograft model, and Ecklonia cava as a whole food has a long history of safe dietary consumption in East Asian cultures, suggesting a generally favorable safety profile. However, comprehensive human safety data including maximum tolerated doses, drug interaction profiles, and contraindications do not currently exist, making definitive safety conclusions impossible. Individuals taking anticoagulants or antidiabetic medications should exercise caution due to dieckol's theoretical anti-platelet and hypoglycemic activity observed in preclinical models.
How does dieckol compare to EGCG as an anti-inflammatory compound?
In a direct head-to-head in vitro comparison in IFN-γ-stimulated HaCaT keratinocytes, dieckol at 12.5 μM suppressed MDC/CCL22 chemokine production more effectively than EGCG (epigallocatechin gallate) at 10 μM, suggesting greater potency in STAT1-mediated inflammatory signaling at comparable concentrations. Both compounds operate through polyphenolic antioxidant and signaling pathway modulation mechanisms, but dieckol's unique phlorotannin scaffold and inhibition of STAT1 Ser727 phosphorylation distinguish its molecular profile from the catechin-based mechanism of EGCG. No human comparative trials exist, so conclusions about clinical superiority cannot be drawn from this single cell-based finding.
Does dieckol have better bioavailability than other Ecklonia cava compounds?
Dieckol is one of the most bioactive phlorotannins found in Ecklonia cava extracts, but like many polyphenols, it has limited oral bioavailability due to poor intestinal absorption and rapid metabolism. Standardized Ecklonia cava extracts that concentrate dieckol content may offer improved bioavailability compared to whole seaweed sources, though absorption rates remain variable between individuals. Research suggests that consuming dieckol with fats or certain foods may enhance absorption, though more human studies are needed to confirm optimal intake conditions.
Can dieckol help with skin conditions like eczema or psoriasis?
Dieckol shows promise for inflammatory skin conditions given its potent suppression of pro-inflammatory chemokine production in human keratinocytes, the primary cells in the skin's outer layer. Studies demonstrate that dieckol can block STAT1 signaling pathways that drive inflammatory responses, potentially benefiting conditions characterized by excessive immune activation like eczema or psoriasis. However, most research to date has been conducted in laboratory and animal models; more clinical trials in humans with specific skin conditions are needed to establish definitive therapeutic claims.
How does dieckol protect against environmental air pollution damage?
Dieckol provides antioxidant protection against particulate matter (PM10)-induced oxidative stress by attenuating lipid peroxidation in skin cells, which is a primary mechanism of pollution-related skin damage. This protective capacity is particularly relevant for individuals living in urban areas with high air pollution exposure, as PM10 particles trigger free radical production that can damage cellular membranes and accelerate skin aging. The antioxidant activity suggests dieckol may help maintain skin barrier integrity against environmental stressors, though research has primarily focused on cellular models rather than human skin studies.
Explore the Full Encyclopedia
7,400+ ingredients researched, verified, and formulated for optimal synergy.
Browse IngredientsThese statements have not been evaluated by the Food and Drug Administration. This content is for informational purposes only and is not intended to diagnose, treat, cure, or prevent any disease.
hermetica-encyclopedia-canary-zzqv9k4w dieckol-ecklonia-cava curated by Hermetica Superfoods at ingredients.hermeticasuperfoods.com and licensed CC BY-NC-SA 4.0 (non-commercial share-alike, attribution required)
